Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
JAMA Oncology|October 20, 2017
Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate CancerJason W D Hearn, Wanling Xie, Mari Nakabayashi, et al.The Journal of Urology|May 19, 2007
Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancerMark Pomerantz, Judith Manola, Mary-Ellen Taplin, et al.Cancer Prevention Research (Philadelphia, Pa.)|September 9, 2011
The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressivenessTong Sun, William K Oh, Susanna Jacobus, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2010
Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian populationTong Sun, Gwo-Shu Mary Lee, William K Oh, et al.The Prostate|December 1, 2011
The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancerTong Sun, Ming Yang, Shaoyong Chen, et al.Cancer|May 31, 2013
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal diseaseMari Nakabayashi, Julia Hayes, Mary-Ellen Taplin, et al.Journal of Oncology Practice|June 26, 2018
Implementation to Optimization: A Tailored, Data-Driven Approach to Improve Provider Efficiency and Confidence in Use of the Electronic Medical RecordSarah S Kadish, Erica L Mayer, David M Jackman, et al.The Journal of Urology|January 28, 2015
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 DiseaseChe-Kai Tsao, Kathryn P Gray, Mari Nakabayashi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancerRobert W Ross, William K Oh, Wanling Xie, et al.Advances in Radiation Oncology|January 24, 2022
Evaluating the Role of Stereotactic Body Radiation Therapy With Respect to Androgen Receptor Signaling Inhibitors for Oligometastatic Prostate CancerVictoria Brennan, Alexander Spektor, Christopher Sweeney, et al.Pageof 7